Sana Biotechnology, Inc. · NASDAQ:SANA
The Vanguard Group's stake in Sana Biotechnology, Inc. fell to 4.81% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Jan 31, 2025
The Vanguard Group's stake in Sana Biotechnology, Inc. fell to 4.81%, 10,747,760 shares, as a passive investor on Dec 31, 2024. Filed Jan 31, 2025 (Schedule 13G/A).
- Stake
- 4.81%
- Shares
- 10,747,760
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 4.81% | 10,747,760 |
Source
Related
- Sana Biotechnology, Inc.
- The Vanguard Group
- Sana Biotechnology, Inc. shareholders
- Form 4 · Bishop Hans Edgar · Oct 6, 2026
- Form 4 · Patel Dhavalkumar Dhirajlal · Aug 27, 2026
- Schedule 13G/A · Robert Nelsen · Aug 14, 2026
- Form 4 · Bishop Hans Edgar · Jul 7, 2026
- Schedule 13G · Ra Capital Management, L.P. · May 21, 2026